A new CAR-T therapy obtains positive results in a high proportion of patients with a refractory type of lymphoma
Dr. Javier Briones, researcher at the Sant Pau Research Institute (Ir Sant Pau) and Josep Carreras Leukemia Research Institute. Credit: ...
